We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

379 hedge funds and large institutions have $4.2B invested in Sabra Healthcare REIT in 2024 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 142 increasing their positions, 111 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.83M

100% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 26

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

29% more capital invested

Capital invested by funds: $3.26B → $4.2B (+$937M)

28% more repeat investments, than reductions

Existing positions increased: 142 | Existing positions reduced: 111

7% more funds holding

Funds holding: 355379 (+24)

4.82% more ownership

Funds ownership: 91.57%96.39% (+4.8%)

Holders
379
Holders Change
+24
Holders Change %
+6.76%
% of All Funds
5.44%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
52
Increased
142
Reduced
111
Closed
26
Calls
$6.99M
Puts
$1.83M
Net Calls
+$5.17M
Net Calls Change
+$2.56M
Name Holding Trade Value Shares
Change
Change in
Stake
RJA
226
Raymond James & Associates
Florida
$391K +$354K +20,987 New
US Bancorp
227
US Bancorp
Minnesota
$390K -$8.29K -492 -2%
Two Sigma Investments
228
Two Sigma Investments
New York
$390K +$10.4K +619 +3%
GFA
229
Gallagher Fiduciary Advisors
Illinois
$381K +$84K +4,981 +32%
AWA
230
Arkadios Wealth Advisors
Georgia
$375K +$6.14K +364 +2%
CM
231
Caption Management
Oklahoma
$372K +$337K +20,000 New
Focus Partners Wealth
232
Focus Partners Wealth
Massachusetts
$372K +$236 +14 +0.1%
VPIM
233
Vanguard Personalized Indexing Management
California
$371K +$17.4K +1,033 +5%
JIR
234
James Investment Research
Ohio
$368K +$164K +9,711 +96%
EFMC
235
Empire Financial Management Company
New York
$367K
DTL
236
Dynamic Technology Lab
Singapore
$366K +$44.7K +2,654 +16%
GRP
237
Global Retirement Partners
California
$350K -$2.83K -168 -0.9%
Cerity Partners
238
Cerity Partners
New York
$342K +$310K +18,361 New
SAM
239
Securian Asset Management
Minnesota
$339K -$4.16K -247 -1%
Cambridge Investment Research Advisors
240
Cambridge Investment Research Advisors
Iowa
$335K -$166K -9,835 -35%
CCM
241
Chilton Capital Management
Texas
$335K +$265K +15,693 +687%
Corient Private Wealth
242
Corient Private Wealth
Florida
$331K -$37.7K -2,238 -11%
AA
243
ALPS Advisors
Colorado
$325K -$10.1K -599 -3%
ATC
244
Argent Trust Co
Tennessee
$317K
DEA
245
DoubleLine ETF Adviser
Florida
$312K +$282K +16,740 New
SG Americas Securities
246
SG Americas Securities
New York
$311K +$282K +16,737 New
SRL
247
Scientech Research LLC
New Jersey
$307K +$278K +16,482 New
PWP
248
Principle Wealth Partners
Connecticut
$303K
PA
249
Parallel Advisors
California
$299K -$18.6K -1,106 -6%
Federated Hermes
250
Federated Hermes
Pennsylvania
$295K -$111K -6,598 -29%

SBRA Hedge Fund Activity: Q3 2024 in Review

379 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2024, worth a combined $4.2B — up 29% from $3.26B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new SBRA positions and 26 closed out — a net gain of 26 holders — while 142 added to existing stakes and 111 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $115M. The largest seller was Janus Henderson Group, cutting an estimated $37.1M.

  • 379 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2024, up from 355 in Q2 2024.
  • Funds reported $4.2B of Sabra Healthcare REIT stock for Q3 2024, up 29% quarter-over-quarter.
  • 52 funds opened new Sabra Healthcare REIT positions in Q3 2024 and 26 closed out, a net change of +26 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2024 was JP Morgan Chase, an estimated $115M added.
  • The largest Sabra Healthcare REIT seller in Q3 2024 was Janus Henderson Group, an estimated $37.1M sold.

Based on aggregated 13F filings for Q3 2024.